Dr. Salome Ewurasi Defore, MD Hospitalist Medicare: May Accept Medicare Assignments Practice Location: 2501 N Patterson St, Valdosta, GA 31602 Phone: 470-316-3378 |
News Archive
Ferring Pharmaceuticals has announced the launch of a Phase IIIB clinical trial of degarelix for injection, a new injectable gonadotropin-releasing hormone (GnRH) receptor antagonist approved by the U.S. Food and Drug Administration (FDA) for the treatment of hormone sensitive advanced prostate cancer.
Sleep disruptions may be among the earliest indicators of Alzheimer's disease, scientists at Washington University School of Medicine in St. Louis report Sept. 5 in Science Translational Medicine.
A tiny fiber-optic sensor has the potential to save lives in open heart surgery, and even during surgery on pre-term babies.
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to scientific advancements in analgesia, announced that the U.S. Food and Drug Administration has accepted for review the New Drug Application for lower dose submicron indomethacin, a non-steroidal anti-inflammatory drug, for the proposed indication of treatment of mild to moderate acute pain in adults.
› Verified 3 days ago